Please sign in to follow a disease.
Esophageal varices
MONDO:0001221Abnormally dilated veins of the esophagus.
Also known as: esophageal varices, esophageal varix, esophagus varicose disease, oesophagus varicose disease, varicose disease of esophagus, varicose disease of oesophagus, bleeding esophageal varices, bleeding oesophageal varices
64 clinical trials for this condition and its sub-types, 34 tagged with Esophageal varices itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Esophageal varices
-
Esophageal varices with bleeding 29 trials
-
Esophageal varices without bleeding 0 trials
-
Does the clock matter? trial tests endoscopy timing for cirrhosis bleeding
Disease control OngoingPeople with liver cirrhosis can develop dangerous bleeding from swollen veins in the esophagus or stomach. Doctors use endoscopy to find and treat the bleeding, but they do not know the best time to do it. This trial randomly assigns patients to different endoscopy timings to see…
Sponsor: General Hospital of Shenyang Military Region • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Common heart drug may stop deadly bleeding in liver patients
Disease control OngoingThis study tests whether beta-blockers, a type of blood pressure medicine, can reduce the risk of bleeding from small varices in people with cirrhosis and portal hypertension. About 763 adults with small varices will receive either beta-blockers or a placebo for up to 3 years. Th…
Phase 4 • Sponsor: King's College Hospital NHS Trust • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Acid-blocking drug may reduce bleeding risk after variceal treatment in cirrhosis patients
Disease control By invitation onlyThis study looks at whether giving pantoprazole (a stomach acid reducer) after endoscopic treatment for enlarged veins in the esophagus or stomach can lower the chance of bleeding in people with liver cirrhosis. About 208 adults will take part. The goal is to see if short-term us…
Sponsor: General Hospital of Shenyang Military Region • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New hope for liver cancer patients: which procedure best prevents dangerous rebleeding?
Disease control OngoingThis study looks at 70 people with liver cancer who had bleeding from enlarged veins in the esophagus. It compares two procedures—an ultrasound-guided injection of a glue-like substance versus a banding technique—to see which better prevents future bleeding. The goal is to find t…
Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Liver cirrhosis patients: new drug may cut rebleeding risk
Disease control By invitation onlyThis study tests whether carvedilol, a newer blood pressure drug, works better than the standard drug propranolol for preventing another bleeding episode in people with liver cirrhosis who have already had variceal bleeding. Both drugs are given alongside a procedure to tie off s…
Phase 4 • Sponsor: Xijing Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Unapproved device tested in early trial
Knowledge-focused OngoingThis trial is testing a medical device that has not been approved or cleared by the U.S. FDA. The study is small and early-stage, focused on understanding how the device works and whether it is safe. No results are available yet, and the device is not ready for widespread use.
Sponsor: C. R. Bard • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC
-
New coil survey aims to improve blood vessel treatments
Knowledge-focused By invitation onlyThis study surveys doctors who use Concerto Versa detachable coils to treat various blood vessel conditions like aneurysms and varicose veins. About 30 patients will be included, and doctors report how well the coils work and any problems within 72 hours. The goal is to collect e…
Sponsor: Medtronic Endovascular • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC